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a b s t r a c t
A previous study has shown that the malolactic fermentation (MLF) was inhibited during sequential fermenta-
tions performedwith the pair Saccharomyces cerevisiae BDX/Oenococcus oeni Vitilactic F in synthetic grape juices.
A yeast peptidic fraction with an apparent MW of 5–10 kDa was involved in the inhibition. In the present study,
the MLF was also inhibited in Cabernet Sauvignon and Syrah wines. The inhibition due to the peptidic fraction
was maintained despite high phenolic contents. Kinetic studies showed that the peptidic fraction was gradually
released during the alcoholic fermentation (AF). Its highest anti-MLF effect was reached when isolated from late
stages of the AF stationary phase. The peptidic fraction was tested in vitro on cell-free bacterial cytosolic extracts
containing the malolactic enzyme in a pH range between 3.5 and 6.7. Results showed that it was able to directly






Antibacterial yeast peptidic compounds
1. Introduction
The production of most red wines and certain white and sparkling
wine styles requires two consecutive fermentation steps. The ﬁrst one
is the alcoholic fermentation (AF) and is carried out by yeasts belonging
mainly to the Saccharomyces cerevisiae species. During this step, the
sugars of the grape must (D-Glucose and D-Fructose) are primarily con-
verted into ethanol and CO2. At the end of the AF, these wines are spon-
taneously or purposely taken through a malolactic fermentation (MLF)
step mostly by indigenous or inoculated lactic acid bacteria belonging
mainly to theOenococcus oeni species. TheMLF, an enzymatic decarbox-
ylation of L-malic acid into L-lactic acid and CO2, reduces wine acidity
and improves its sensorial characteristics and its microbial stability
(Bartowsky et al., 2002; Lonvaud-Funel, 1999, 2002). However, it is
often difﬁcult to trigger and accomplish because of the individual or
synergistic antibacterial activity of several physical chemical wine pa-
rameters and yeast inhibitory metabolites. Some of these factors have
been intensively investigated such as low pH (Britz and Tracey, 1990;
Vaillant et al., 1995), inadequate temperature (Britz and Tracey, 1990),
nutrient depletion (Patynowski et al., 2002; Remize et al., 2006; Saguir
andManca de Nadra, 2002; Terrade andMira de Orduna, 2009), endog-
enous and exogenous SO2 (Carreté et al., 2002; Henick-Kling and Park,
1994; Larsen et al., 2003; Osborne and Edwards, 2006), phenolic com-
pounds (Reguant et al., 2000), high ethanol content (Britz and Tracey,
1990; Vaillant et al., 1995) and medium chain fatty acids (Capucho
and San Romao, 1994; Edwards and Beelman, 1987; Lonvaud Funel et
al., 1988).
While the anti-MLF role of the previous compounds is already well
established, there are gradually growing evidences suggesting the in-
volvement of yeast peptides/proteins in the inhibition of O. oeni growth
and L-malic acid consumption. So far, few authors have demonstrated
the ability of certain S. cerevisiae strains to produce anti-MLF com-
pounds of protein nature. Besides, the compounds found presented dif-
ferent MW and were strain dependent. Dick et al. (1992) were the ﬁrst
to isolate two antibacterial cationic proteins produced by the yeast
strain R107. One of them had the characteristics of lysozyme and the
other one was a small protein with a high pI. Later on, Comitini et al.
(2005) found that S. cerevisiae F63 was able to produce a proteinaceous
compound with a MW N10 kDa that strongly inhibited the growth of O.
oeni CHR as well as its MLF. Besides, Osborne and Edwards (2007),
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identiﬁed a 5.9 kDa peptide produced by S. cerevisiae RUBY. Ferm and
inhibiting O. oeni Viniﬂora oenos. Mendoza et al. (2010) showed that
S. cerevisiae mc2 released a proteinaceous compound presenting a
MW between 3 and 10 kDa that inhibited the growth of O. oeni X2L
but not its ability to consume L-malic acid. Finally, Branco et al. (2014)
showed that S. cerevisiae CCMI 885 secreted antimicrobial peptides
(AMP) that were active against a wide variety of wine-related yeasts
in addition to O. oeni. However, only themicrobial growth was evaluat-
ed. These AMP corresponded to different fragments of the C-terminal
amino acid sequence of the S. cerevisiae glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH)enzyme. Among these AMP, twomain fragments
of 1.638 and 1.622 kDa were detected.
Most of the time, the impact of these compounds on the growth ofO.
oeni was the main parameter evaluated and few data concerning the
malate consumption was given. The MLF inhibition was often consid-
ered as a consequence of the bacterial growth inhibition. Besides, the di-
rect effect of these compounds on the malolactic enzyme activity was
never studied.
In a previous work (Nehme et al., 2010), we demonstrated that S.
cerevisiae BDX (referred to as strain D) was able to produce a peptidic
fraction with an apparent MW between 5 and 10 kDa responsible for
the strong inhibition ofO. oeniVitilactic F (referred to as strain X) during
sequential fermentations performed in synthetic grape juices. Sequen-
tial fermentations simulate the natural winemaking process by starting
the MLF after the accomplishment of the AF. In the present work, we
intended to further characterize this peptidic fraction; ﬁrst by showing
its ability to inhibitMLF in naturalwines despite high phenolic contents,
second by determining the time of its release during AF and third by
measuring its direct inhibitory effect on the malolactic enzyme activity.
2. Materials and methods
All culture media components were supplied by Sigma-Aldrich
(Taufkirchen-Germany) except for the Yeast Extract and the peptone
that were supplied by Oxoid (Hampshire-England).
2.1. Strains and storage conditions
S. cerevisiaeBDX andCY3079 andO. oeniVitilactic F used in thiswork
were kindly provided by Lallemand Inc. (Blagnac, France). In previous
works, BDXwas referred to as strain D, CY3079 as strain A and Vitilactic
F as strain X (Nehme et al., 2008, 2010). Yeast stock cultures were kept
at 4 °C in YEPD (Yeast Extract Peptone Dextrose) agar slants composed
of 10 g/L Yeast Extract, 20 g/L peptone, 20 g/L D-glucose and 20 g/L agar.
The bacterial strain was kept frozen at−20 °C in MRS (De Man, Rogosa
and Sharpe) broth containing 20% glycerol (v/v).
2.2. Growth media
2.2.1. Synthetic grape juice medium (SGJ medium)
The medium composition that simulated the natural grape juice
consisted of: D-glucose 100 g/L, D-fructose 100 g/L, Yeast Extract 1 g/L,
(NH4)2SO4 2 g/L, citric acid 0.3 g/L, L-malic acid 3 g/L, L-tartaric acid
5 g/L, MgSO4 0.4 g/L, and KH2PO4 5 g/L, pH adjusted to 3.5 using a
10 mol/L NaOH solution. The medium was autoclaved before use
(121 °C, 20 min).
2.2.2. Cabernet Sauvignon and Syrah grape musts
Cabernet Sauvignon (CS) and Syrah grape varieties were provided
by Clos Saint Thomas (Kab Elias, Lebanon) in September 2014. The
grapes were destemmed and crushed then submitted to pre-fermenta-
tion macerations at 10, 60, 70 and 80 °C for 48 h. The grape musts were
sulﬁtized at a dose of 5 g/hL. A solution of NaHSO3 100 g/L was used for
this purpose. The sugar and L-malic acid concentrations were adjusted
to 200 g/L and 3 g/L respectively. The pH was also adjusted to 3.5
using an 85% orthophosphoric acid solution.
2.2.3. Modiﬁed MRS medium
The MRS medium was supplemented with L-malic acid (3 g/L) and
Tween 80 (1 mL). After autoclaving (121 °C, 15 min), 10% ethanol (v/
v) were aseptically added through sterile ﬁlter membranes of 0.22 μm
cut-off (Elvetec services, Meyzieu-France) and the pH was adjusted to
3.5 using an 85% orthophosphoric acid solution.
2.3. Sequential fermentations in natural grape musts
The Cabernet Sauvignon and Syrah grape musts were separately in-
oculated either by S. cerevisiae BDX or by S. cerevisiae CY3079 at an ini-
tial concentration of 3 × 106 cells/mL (Thoma counting chamber). The
AF was followed until total or cessation of sugar consumption (b2 g/
L). The yeast inoculum was beforehand prepared in two steps. First, a
preculture of the yeast strainwas obtained by reactivating the stock cul-
ture in YEPD broth for 24h. Second, the preculturewasused to inoculate
a low sugar concentration synthetic grape juice medium: D-Glucose
50 g/L and absence of D-Fructose. This step was carried out for 24 h
and provided the yeast inoculum.
After completion of the AF, the wines were subjected to different
steps before inoculation of the lactic acid bacteria. First, yeast cells
were removed by centrifugation (3000 rpm for 20 min at 4 °C) and
the supernatants were recovered. Then, the L-malic acid concentration
was measured and readjusted to 3 g/L. Next, the pH was adjusted to
3.5 using a 10 mol/L NaOH solution. Finally, the wines were ﬁltered
aseptically through 0.22 μmmembranes (Elvetec services) andwere in-
oculated with the malolactic bacteria at an initial concentration of
2 × 106 cells/mL (Petroff-Hausser counting chamber) corresponding
to an initial bacterial biomass of 0.0016 g/L. The MLF was followed
until cessation of L-malic acid consumption. The bacterial inoculum
was prepared in two steps. First, a preculture of O. oeni Vitilactic F was
obtained by reactivating the stock culture inMRS broth with 3% ethanol
(v/v) added. After 24 h, the preculture was used to inoculate the low
sugar concentration synthetic grape juice medium with 6% ethanol (v/
v) added. This step provided the bacterial inoculum after an incubation
period of 24 h.
All fermentation steps for both AF andMLFwere carried out at 22 °C
with stirring at 150 rpm in Erlenmeyer ﬂasks.
Yeast and bacterial growth were followed during AF and MLF re-
spectively by measuring their cell concentration (cells/mL) and their
dry weight (g/L).
Each sequential fermentation was performed in three independent
replicates.
2.4. Timing of the release of the 5–10 kDa peptidic fraction produced by S.
cerevisiae BDX during AF
TheAFwas carried out by S. cerevisiae BDX for 5 days (120 h) in 2 L of
the SGJ medium. Each 24 h, a supernatant of 210 mL was collected and
fractionated by ultraﬁltration in order to isolate the corresponding 5–
10 kDa peptidic fraction. First, the sample was distributed into centrifu-
gal ﬁlter units' presenting a cut-off of 10 kDa (Amicon® Ultra-15 with
ultracel-10 membrane) and the ultraﬁltration was performed at
3500 g for 45 min at 4 °C. Each unit can initially contain a volume of
15mL. 14 units were ﬁlled and at the end of the ultraﬁltration, a volume
of 0.2 mL was retained by the membrane of each unit. A total retentate
of 2.8mLwith aMW ≥ 10kDa, 75 times concentrated,was obtained. The
ﬁltrate ≤10 kDa was then recovered and ultraﬁltered using the centrif-
ugal ﬁlter units presenting a cut-off of 5 kDa (Corning® Spin-X UF 20
Sigma-Aldrich). The principle was the same and 2.8 mL of a fraction
with aMWbetween5 and 10 kDa, 75 times concentrated,was obtained.
Five fractions were ﬁnally collected at the end of the AF (after 120 h).
They were referred to as D1 (24 h), D2 (48 h), D3 (72 h), D4 (96 h)
and D5 (120 h). The fraction from each day (2.8 mL) was added to a
modiﬁed MRS medium so as to obtain a ﬁnal volume of 20 mL and
was ﬁnally 10.5 times concentrated.
O. oeni Vitilactic F was then inoculated into these media at an initial
concentration of 2 × 106 cells/mL and the MLF was carried out at 22 °C
with stirring at 150 rpm in Erlenmeyer ﬂasks. The same modiﬁed MRS
medium without the 5–10 kDa fractions was used as a control for this
experiment. The MLF was followed by regular sampling until the cessa-
tion of the L-malic acid consumption.
The timing experiment was performed in three independent
replicates.
2.5. In vitro evaluation of the inhibitory effect of the 5–10 kDa fractions on
the malolactic enzyme activity
2.5.1. Preparation of the cell-free bacterial enzymatic extract comprising
the malolactic enzyme
ThemodiﬁedMRSmediumwas inoculatedwithO. oeniVitilactic F at
an initial concentration of 2 × 106 cells/mL and the bacterial culturewas
followed for 5 days at 22 °C with stirring at 150 rpm. After a centrifuga-
tion at 3500 rpm for 20 min at 4 °C, the supernatant was removed and
0.4 g of the bacterial pellet were weighed and suspended in 800 μL of
an appropriate buffer (citrate buffer pH 3.5, phosphate buffer pH 6 or
phosphate buffer pH 6.7, buffer concentration 0.1 M). The bacterial
cells were then lysed by vortexing them with glass beads of 300 μm di-
ameter (Sigma-Aldrich) in a FastPrep® FP120 bead-beater device (BIO
1010/Savant) at 6 m/s for 3 × 45 s at 4 °C. Between 2 consecutive
runs, the cells were kept on ice for 1 min. The cell debris was removed
by centrifugation at 14,000 g for 10 min at 4 °C (Larsen et al., 2006).
The supernatant containing the cell-free enzymatic extract was recov-
ered and the volume completed to 2mL using the corresponding buffer.
2.5.2. Monitoring of the L-malic acid consumption in vitro
The 2 mL of the enzymatic extract were divided into 2 aliquots of
1 mL each. One was used as a control and the other as a test medium
to which the 5–10 kDa fractions were added. The reaction mixture is
given in Table 1. The reagents were added to each aliquot in the order
listed in the table. The enzymatic reaction was performed at 30 °C for
30 min at pH 6, 40 min at pH 6.7 and 70 min at pH 3.5.
The inhibitory kinetic of the malolactic enzyme activity by the 5–
10 kDa fractionswas evaluated. The 5 peptidic fractions of 5–10 kDa col-
lected from D1 to D5 (Section 2.4) were tested separately. At the end of
each assay, the concentrations of the L-malic acid consumed and the L-
lactic acid produced were measured in both aliquots (control and test)
and compared.
The inhibitory effect of each 5–10 kDa fraction on themalolactic en-
zyme activity was performed in three independent replicates.
2.6. Analytical methods
2.6.1. L-malic acid consumption
The L-malic acid concentration was determined using an enzymatic
assay (Boehringer Mannheim/R-Biopharm, kit. No 10139068035,
Darmstadt-Germany) and the results were expressed in g/L.
2.6.2. L-lactic acid production
The L-lactic acid concentration was determined using an enzymatic
assay (Boehringer Mannheim/R-Biopharm, kit. No 10139084035,
Darmstadt-Germany) and the results were expressed in g/L.
2.6.3. Total polyphenols
Total polyphenols in Cabernet Sauvignon and Syrah wines were
evaluated at the end of the AF carried out by both yeast strains. The
method used was based on the reduction of the Folin-Ciocalteu reagent
by polyphenols as described by Ribéreau-Gayon et al. (2006). The re-
sults were expressed in mg/L equivalent gallic acid.
2.6.4. Dry weight of bacteria
The dry weight was determined using a thermobalance or moisture
analyzer (Ohaus-UK). A correlation between the bacterial cell concen-
tration (cells/mL) and the bacterial biomass (g/L) was established
using high bacterial concentrations. The correlation obtained was the
following:
y g=Lð Þ ¼ 8:10
−10$ cells=mLð Þ:
It was then used to determine the biomass of low concentrated
samples.
2.7. Statistical analyses
Means and standard deviations of the assays were calculated using
conventional statistical methods. Each experiment was performed in
three replicates. Statistical analysis (ANOVA) was applied to the data
to determine differences (p b 0.05). Means differences were made by
using Tukey's HSD test. The statistical analysis was carried out using
Statgraphics XV·I for windows.
3. Results and discussion
3.1. Impact of the 5–10 kDa peptidic fraction produced by S. cerevisiae BDX
on MLF in natural winemaking conditions
It was previously shown that the growth of O. oeni Vitilactic F and its
ability to consume L-malic acid were strongly inhibited by S. cerevisiae
BDX during sequential fermentations performed in synthetic grape
juice (SGJ) media. TheMLF inhibitionwasmainly due to a peptidic frac-
tion presenting an apparentMWof 5–10 kDaworking synergically with
ethanol (Nehme et al., 2010). The SO2 and medium chain fatty acids
concentrations produced by S. cerevisiae BDX were lower than the
ones found in the literature to cease MLF and the nutrient depletion
was excluded from inhibitory factors (Nehme et al., 2008, 2010). S.
cerevisiae CY3079 produced similar amounts of ethanol, SO2 and medi-
um chain fatty acids as S. cerevisiae BDX and presented the same nutri-
tional behavior. MLF carried out by O. oeni Vitilactic F in SGJ media
fermented by CY3079 was totally accomplished (Nehme et al., 2008).
Besides, 5–10 kDa peptidic fractions isolated from SGJ media fermented
by CY3079 did not inhibitO. oeniVitilactic F (data not published). There-
fore CY3079 was chosen as a reference yeast strain for this study.
Table 2 shows the total phenolic content at the end of the AF carried
out by S. cerevisiae BDX and S. cerevisiae CY3079 in Cabernet Sauvignon
and Syrahwines. The corresponding grape musts were previously mac-
erated at 10, 60, 70 and 80 °C for 48 h before AF. High phenolic contents
were reached atmaceration temperatures of 60, 70 and 80 °C because of
a better phenolic extraction from the grape skin and seeds. Sequential
fermentations were carried out in these wines by inoculating O. oeni
Vitilactic F at the end of the AF. MLF was monitored for 3 months and
was totally inhibited in wines fermented by S. cerevisiae BDX. Both the
bacterial growth and the malate consumption were repressed regard-
less of the phenolic content (Tables 2 and 3). Despite high phenolic
Table 1
Reaction mixture for themonitoring of the L-malic acid consumption in vitro by themalo-
lactic enzyme of the enzymatic extract isolated from O. oeni Vitilactic F at different pH
values with or without the 5–10 kDa peptidic fractions.
Aliquot 1 (control) Aliquot 2 (test) Amounts
Enzymatic extract Enzymatic extract 1 mL
Mn2+ Mn2+ 0.1 mg
NAD+ (35 g/L) NAD+ (35 g/L) 0.1 mL
Buffera ABPb (10.5×) 0.14 mL
L-malic acid (1 g/L) L-malic acid (1 g/L) 1 mg
a ABP (10.5×): antibacterial peptides of the 5–10 kDa fractions 10.5 times concentrated.
b Buffer: 0.1 mol/L of citrate buffer pH 3.5, phosphate buffer pH 6 or phosphate buffer
pH 6.7.
contents, MLF conducted by O. oeni Vitilactic F in wines produced by S.
cerevisiae CY3079 was totally completed. In comparison to the pre-fer-
mentation maceration at 10 °C, the higher phenolic content obtained
at 60, 70 and 80 °C reduced the bacterial biomass produced and slowed
down the MLF but malate was totally consumed (Table 3).
Therefore, MLF results were reproducible in both synthetic and nat-
ural grape juice media with both yeasts/bacteria pairs tested.
The conservation of the inhibitory effect due to the 5–10 kDa yeast
peptidic fraction in naturalwinemaking conditions despite the presence
of phenolic compounds is an interestingﬁnding. It is usually known that
phenolic compounds are able to interact with proteins leading either to
their precipitation or to changes of their bioactive properties (Sims et al.,
1995; Yokotsuka and Singleton, 1995). Wine proteins derive mostly
from grapes but also from yeasts during AF. Both reversible (van der
Waals forces, hydrogen bonding and hydrophobic binding) and irre-
versible (covalent bonds) interactions are involved. Proline rich pro-
teins like collagen, gelatin and casein, which are commonly used as
protein ﬁning agents in wine, and some salivary proteins reported to
be involved in astringency perception, are particularly prone to interact
with phenolic compounds. The precipitation depends on the phenols
and proteins type and concentration (McRae and Kennedy, 2011;
Ozdal et al., 2013).
Few studies investigated the possible interactions between peptides
of lowMWand phenolic compounds inwine. Besides, no previous stud-
ies dealt with peptides from wine origin. Yokotsuka and Singleton
(1995) demonstrated that gelatin peptides (2, 5 and 10 kDa) and syn-
thetic peptides of low MW (between 1.3 and 2.5 kDa) were very effec-
tive forﬁningwines, at least at the same levels aswhole gelatin (70 kDa)
with high afﬁnity for phenols. The afﬁnity depended on the pH and tem-
perature. Osborne and Edwards (2007) found that S. cerevisiae RUBY.
Ferm was able to produce a peptide of 5.9 kDa that inhibited O. oeni
Viniﬂora oenos during sequential fermentations in synthetic grape
juice media lacking phenols. However, Larsen et al. (2003) who previ-
ously used the same strains combination were able to successfully
achieve MLF in Chardonnay wines. Therefore, it was suggested that
the Chardonnay wine contained phenolic compounds that may have
interacted with the 5.9 kDa peptide.
The 5–10 kDa peptides of this studymay have not presented binding
sites for phenolic compounds and thuswere not removed. Regardless of
the different types and concentrations of phenolic compounds, the
inhibition caused by the 5–10 kDa peptidic fraction released by S.
cerevisiae BDX was preserved in natural winemaking conditions.
3.2. Timing of the release of the 5–10 kDa anti-MLF peptidic fraction pro-
duced by S. cerevisiae BDX during AF
In order to assess the timing of the release of the 5–10 kDa peptidic
fraction, the AF in the SGJ medium was followed until total sugar con-
sumption. It lasted 120 h whereas the stationary growth phase started
after 50 h. A peptidic fraction of 5–10 kDa was collected each 24 h of
the AF. Five fractions were obtained and each one was tested in a mod-
iﬁedMRSmediumwhere it was ﬁnally 10.5 times concentrated. The re-
sults were compared with those obtained in a modiﬁed MRS control.
Fig. 1a shows that the growth kinetic proﬁles of O. oeni Vitilactic F in
the presence of the fractions collected after 24, 48 and 72 h were very
similar. Although the average speciﬁc growth rates were identical to
that of the control (0.009 h−1), the ﬁnal biomass reached (0.072 g/L)
was 10% less than the one obtained in the control (0.08 g/L) (Table 4).
When the fractions collected after 96 and 120 hwere tested, the speciﬁc
growth rates were slightly higher (0.013 h−1, p b 0.05), but the maxi-
mum biomass reached (0.03 g/L) was reduced by 62.5% compared to
the control (Table 4). Moreover, a decline phase was detected with
these two fractions leading to the death of the whole population with
the last fraction (120 h).
The malate was totally consumed in the presence of the fractions
collected after 24 h (D1), 48 h (D2) and 72 h (D3) butwith a gradual de-
crease of the consumption kinetics (Fig. 1b and Table 4). The average
speciﬁc rate of malate consumption in the presence of the fraction D1
was similar to that of the control (0.37 g g−1 h−1, p N 0.05). In the pres-
ence of the fractions D2 and D3, the speciﬁc rates were 23% lower than
in the control (p b 0.05). The fractions taken after 96 h (D4) and 120 h
(D5) of AF were the most inhibiting ones as only 0.37 and 0.19 g/L of
L-malic acid were consumed reducing the control speciﬁc rate of 57
and 77% respectively (p b 0.05).
Therefore, we can conclude that the 5–10 kDa peptidic fraction was
gradually released during AF and reached its maximum inhibitory con-
centration at late stages of the yeast stationary phase (96 and 120 h). Its
effect started to be detectable with the fraction D2 (48 h) which
corresponded to the end of the AF exponential growth phase, reducing
Table 2
Total phenolic content (mg/L equivalent gallic acid) in Cabernet Sauvignon and Syrah wines at the end of the AF carried out by S. cerevisiae CY3079 and S. cerevisiae BDX.a
Pre-fermentation maceration temperature (°C) Cabernet Sauvignon wine Syrah wine Cabernet Sauvignon wine Syrah wine
Phenolic content at the end of the AF carried out by
S. cerevisiae CY3079 (mg/L)
Phenolic content at the end of the AF carried out by
S. cerevisiae BDX (mg/L)
10 513 ± 18 365 ± 7 868 ± 18 378 ± 32
60 2635 ± 21 2425 ± 106 2925 ± 7 2718 ± 117
70 3725 ± 21 3043 ± 88 3978 ± 11 3645 ± 170
80 2985 ± 21 2295 ± 35 3078 ± 11 2585 ± 42
a Results are mean ± SD values of three replications.
Table 3
Growth of O. oeni Vitilactic F and malate consumption during MLF performed in the Syrah and Cabernet Sauvignon wines obtained after AF by S. cerevisiae CY3079 or S. cerevisiae BDX.a
Pre-fermentation maceration
temperature (°C)
AF carried out by S. cerevisiae CY3079 AF carried out by S. cerevisiae BDX
Cabernet Sauvignon wine Syrah wine Cabernet Sauvignon wine Syrah wine
10 60, 70 and 80 10 60, 70 and 80 10 60, 70 and 80 10 60, 70 and 80
Bacterial biomass produced (g/L) 0.120 ± 0.005 0.080 ± 0.004 0.120 ± 0.006 0.080 ± 0.004 0.0024 ± 0.0002 0.0004 ± 0 0.0044 ± 0.0002 0.0004 ± 0
Consumed L-malic acid (g/L) 3.00 ± 0.06 3.00 ± 0.06 3.00 ± 0.06 3.00 ± 0.06 0 ± 0 0 ± 0 0 ± 0 0 ± 0
Experiment duration (days)b 30 45 30 45 90 90 90 90
a The experiment was followed until total consumption of L-malic acid (30 and 45 days) in wines produced by S. cerevisiae CY3079 (non-inhibitory strain). Although malate was not
consumed, it was followed for 90 days in wines produced by S. cerevisiae BDX (inhibitory strain).
b Results are mean ± SD values of three replications.
mainly the rate of malate consumption. The same was noticed with the
fraction D3 (72 h). The strong inhibition of malate consumption with
the fractions D4 (96 h) and D5 (120 h) can somewhat explain the
weak ﬁnal biomasses formed. It is known that MLF produces ATP
through a chemiosmotic mechanism thus enhancing the bacterial
growth (Bouix and Ghorbal, 2015; Cox and Henick-Kling, 1995). The
MLF is one of the main sources of energy for bacteria in winemaking
conditions. Therefore, an inhibition of malate consumption can also af-
fect the bacterial growth.
Information about the timing of the release of antibacterial peptides/
proteins is scarce and to our best knowledge no previous work has de-
scribed simultaneously the kinetics of their production and the kinetics
of their anti-MLF activity. Albergaria et al. (2010) showed that S.
cerevisiae CCMI 885 started to secrete three antifungal peptides of
about 6, 4.5 and 4 kDa at the end of the AF exponential growth phase
(day 2) with a gradual increase of their concentration during the sta-
tionary growth phase (days 4 and 7). Later on, Branco et al. (2014)
who used the same yeast strain demonstrated that these peptides
were also active against the growth of O. oeni and corresponded to
GAPDH-derived peptides of 1.6 kDa. They suggested that the peptides
were released by apoptotic yeast cells during the stationary phase. In
fact, Silva et al. (2011) showed that GAPDH is presumably a substrate
of metacaspases during apoptosis. Our ﬁndings present some similari-
tieswith these conclusions since themost important antibacterial effect
was detected with the fractions obtained from late stationary phase.
However, further investigation must be carried out to see if any of the
5–10 kDa peptides is possibly a GAPDH fragment.
The timing results are in accordancewith the co-culture results pub-
lished by Nehme et al. (2010) who demonstrated that the co-culture
strategy improved the MLF output with the same pair (S. cerevisiae
BDX/O. oeni Vitilactic F). During co-cultures, AF and MLF were conduct-
ed simultaneously by inoculating yeasts and bacteria at the same time
from the beginning in a membrane bioreactor using the same experi-
mental conditions. The bacterial growth was twice better and 74% of
the initial malate were successfully consumed in 3 weeks without any
risk of increased volatile acidity or off-ﬂavors. Although the 5–10 kDa
peptides gradually appeared during the AF as demonstrated by the
present study, the MLF was improved. More recently, co-inoculation
was suggested as aworthwhile alternative forwinemaking both for bet-
ter malate consumption and sensorial characteristics when compared
with the traditional sequential inoculation (Cañas et al. 2015; Versari
et al., 2015; Tristezza et al., 2016).
Information about the timing of the release of the inhibitory pep-
tides is very useful for the determination of the best moment for bacte-
rial inoculation and for an optimum extraction of the targeted
molecules.
3.3. In vitro evaluation of the malolactic enzyme inhibition by the 5–10 kDa
peptidic fractions
In this experiment, the malolactic enzyme of the cell-free bacterial
enzymatic extract was directly exposed to the inhibitory peptides. The
ﬁve fractions of 5–10 kDa collected each 24 h of the AF (D1 to D5)
were tested as described in Table 1. Table 5 shows the amounts of L-
malic acid consumed, L-lactic acid produced and the inhibition percent-
age of malate consumption for each 5–10 kDa fraction tested at pH 6.7.
For pH 6 and 3.5, only the values of the inhibition percentage of malate
consumption are given.
Theﬁrst set of experimentswas conducted at pH6.7which is around
the cytoplasmic pH of the majority of lactic acid bacteria. First, the re-
sults clearly show that the 5–10 kDa fractions were able to reduce the
amount of L-malic acid consumed of 28% (D1) to 91% (D5) when com-
pared to the control, thus exhibiting a direct inhibitory effect on thema-
lolactic enzyme activity (p b 0.05). The ethanol concentration in the ﬁve
fractions was evaluated and a residual amount of 0.02 g/L was found in
the 5–10 kDa fraction corresponding to D5. Therefore, all the fractions
were ethanol free and the inhibition observedwas only due to the pres-
ence of the peptides. Second, the kinetic of the inhibition was in agree-
ment with the results of the timing experiment (Fig. 1b) proving once
again that the 5–10 kDa peptidic fraction was gradually released during
the AF with the highest concentration reached at the end of the station-
ary phase. Third, it is known that during the malolactic fermentation,
each mole of L-malic acid decarboxylated by the malolactic enzyme re-
leases onemole of L-lactic acid and onemole of CO2. Therefore, themea-
surement of the lactate produced was an additional indicator of the
malolactic enzyme activity. The amounts of L-lactic acid produced
were measured and found to be stoichiometrically equivalent to the
amounts of L-malic acid consumed. As an example, in the presence of
the fraction D1, 0.72 g/L of L-malic acid equivalent to 5.4 mmol/L were
consumed and gave 0.48 g/L of L-lactic acid which corresponded to
5.3 mmol/L. Consequently, the gradual decrease in the amount of L-lac-
tic acid produced proved that the 5–10 kDa peptidic fractions targeted
Fig. 1. Growth (a) and malic acid consumption (b) kinetics of O. oeni Vitilactic F in the
control and in the presence of the 5–10 kDa inhibitory fractions collected at different
intervals of the AF. (♦) Control: modiﬁed MRS medium, (■) 5–10 kDa collected after
24 h of the AF (D1), (▲) 5–10 kDa collected after 48 h of the AF (D2), (×) 5–10 kDa
collected after 72 h of the AF (D3), (○) 5–10 kDa collected after 96 h of the AF (D4), (●)
5–10 kDa collected after 120 h of the AF (D5). Each value is the mean of triplicate
experiments ± SD.
speciﬁcally the malolactic enzyme and not any other enzyme of the cy-
tosolic extract.
5–10 kDa fractions isolated from the SGJ media fermented by S.
cerevisiae CY3079 (reference strain or non-inhibitory strain) were also
tested and gave results similar to the control (data not shown). In fact,
the 1 g/L of L-malic acid were totally decarboxylated by the malolactic
enzyme in the presence of these fractions showing no inhibition. There-
fore, the inhibition of the malolactic enzyme by the 5–10 kDa peptides
of S. cerevisiae BDX was highly speciﬁc.
The same experiment was repeated by changing the pH (Table 5).
The pH 6 was chosen because it is the optimum pH for activity of the
malolactic enzyme of O. oeni (Schümann et al., 2013). The inhibition of
malate consumption gradually increased in the presence of the 5–
10 kDa fractions leading to the same conclusions obtained at pH 6.7.
However, the reaction was faster. 30 min instead of 40 min were re-
quired to entirely decarboxylate 1 g/L of L-malic acid into L-lactic acid
and CO2 in the control. The pH 3.5 was also tested because it represents
the pH of wine at the beginning of theMLF in this study. At this extreme
pH, similar results were also obtained. However, the reaction was the
slowest and took 70 min in the control. Interestingly, Bouix and
Ghorbal (2015) demonstrated that at low extracellular pH, O. oeni
cells were able to drop their intracellular pH to values as low as 3.5
(equal to the extracellular pH). The MLF was then initiated indicating
that the malolactic enzyme was active at this low pH. During MLF, the
intracellular pH increased again due to theproton extrusion that accom-
panied the release of lactate and CO2. It reached 6 at the end of the MLF
and dropped again to 3.5 when the malate was totally consumed. The
results of the in vitro experiment performed at 3.5 showed that the en-
zymewas indeed active at this low pH although the enzymatic reaction
was 2.3 times slower than at pH 6 (Table 5).
From theprevious results, it can be concluded that the peptideswere
able to exert their inhibitory effect in a pH range between 3.5 and 6.7.
The results also suggest that in vivo, the peptides of the 5–10 kDa
fraction released by S. cerevisiae BDX would enter the bacterial cells by
mechanisms yet to be identiﬁed and directly inhibit the malolactic en-
zyme. The presence of cell receptors to these peptides could be
suggested.
No previous works have shown the involvement of yeast proteina-
ceous metabolites in the direct inhibition of the malolactic enzyme ac-
tivity. Few have attempted to explain the mechanism of action of the
yeast antibacterial peptides/proteins and evaluated mainly their impact
on the bacterial growth. The proteinaceous compound ≥10 kDa found
by Comitini et al. (2005), was dose dependent and was able to reduce
the bacterial growth with a typical saturation kinetic thus suggesting
the presence of a receptor on the bacterial cell. Therefore its bacterio-
static or bactericidal effect depended on its concentration and the MLF
inhibitionwas correlated to its bactericidal effect. The 3–10 kDapeptidic
fraction found by Mendoza et al. (2010) inhibited the bacterial growth
but not themalate consumptionwith a typical saturation kinetic similar
to that suggested by Comitini et al. (2005). Osborne and Edwards
(2007) suggested that the antibacterial peptide of 5.9 kDa worked syn-
ergically with SO2. The mechanism proposed was that of bacteriocins
Table 4
Determination of the average speciﬁc growth rates and the average speciﬁc rates of malate consumption during theMLF carried out byO. oeniVitilactic F in themodiﬁedMRSmedia con-


















X0: Initial biomass (g/L) 0.0016 ± 0.0002 0.0016 ± 0.0002 0.0016 ± 0.0002 0.0016 ± 0.0002 0.0016 ± 0.0002 0.0016 ± 0.0002
Xf: Final biomass (g/L) 0.080 ± 0.006 0.072 ± 0.006 0.073 ± 0.005 0.072 ± 0.006 0.031 ± 0.002 0.030 ± 0.002
dt1: Growth duration (h) 216 216 216 216 144 144
μ
3: average speciﬁc growth
rate (h−1)
0.009 ± 0.001a 0.009 ± 0.001a 0.009 ± 0.001a 0.009 ± 0.001a 0.013 ± 0.002b 0.013 ± 0.001b
S0: Initial L-malic acid (g/L) 3.25 ± 0.16 3.01 ± 0.16 3.03 ± 0.20 3.03 ± 0.15 3.04 ± 0.15 3.09 ± 0.12
Sf: Final L-malic acid (g/L) 0 ± 0 0.03 ± 0 0 ± 0 0 ± 0 2.67 ± 0.12 2.90 ± 0.16
dt2: Duration of MLF (h) 216 216 288 288 144 144
Qs
4: average speciﬁc rate of
malate consumption
(g g−1 h−1)
0.37 ± 0.02a 0.375 ± 0.020a 0.28 ± 0.02b 0.290 ± 0.015b 0.16 ± 0.01c 0.084 ± 0.006d
1 Results are mean ± SD values of three replications. In comparison to the control, values of average speciﬁc rates (growth or malate consumption) within the same row followed by
different letters are signiﬁcantly different (p b 0.05) according to Tukey's HSD test.
2
μ (h−1) = (dX / dt1).1/X with dX= (Xf− X0) and X = (Xf + X0) / 2.
3 Qs (g g
−1 h−1) = (dS / dt2).1/X with dS = (S0− Sf) and X = (Xf + X0) / 2.
4 D1 to D5 (day 1 to day 5): 5–10 kDa fractions collected at 24, 48, 72, 96 and 120 h of the AF performed by S. cerevisiae BDX.
Table 5
Amount of L-malic acid consumed (g/L) and L-lactic acid produced (g/L) during the enzymatic reaction in vitro performed at different pH in the presence of the 5–10 kDa fractions (ABP)
collected each 24 h of the AF.1














Inhibition % of malate
consumption2
Inhibition % of malate
consumption
Inhibition % of malate
consumption
Control 3(absence of ABP) 1.00 ± 0.02a 0.670 ± 0.013a 0 ± 0 0 ± 0 0 ± 0
After 24 h of the AF (D1) 0.720 ± 0.015b 0.48 ± 0.01b 28.0 ± 0.6 8.00 ± 0.16 7.30 ± 0.15
After 48 h of the AF (D2) 0.630 ± 0.013c 0.420 ± 0.009c 37.0 ± 0.8 15.0 ± 0.3 14.6 ± 0.3
After 72 h of the AF (D3) 0.560 ± 0.011d 0.380 ± 0.008d 44 ± 1 30.0 ± 0.6 32.30 ± 0.65
After 96 h of the AF (D4) 0.100 ± 0.002e 0.070 ± 0.002e 90 ± 2 90.4 ± 2.0 94 ± 2
After 120 h of the AF (D5) 0.090 ± 0.002f 0.060 ± 0.002f 91 ± 2 94 ± 2 100 ± 2
1 Results aremean±SDvalues of three replications. In comparison to the control, values ofmalate consumed and lactate produced followedbydifferent letterswithin the same column
are signiﬁcantly different (p b 0.05) according to Tukey's HSD test.
2 Inhibition % of malate consumption = (consumed L-malic acid in the control− consumed L-malic acid in the presence of ABP) × 100 / (consumed L-malic acid in the control).
3 Absence of ABP: absence of antibacterial peptides.
forming membrane pores and facilitating the entry of SO2 inside the
cells thus leading to the bacterial death and arrest of MLF. The mecha-
nism of action of the GAPDH-derived peptides identiﬁed by Branco et
al. (2014) and that inhibited the growth of O. oeni was not elucidated.
In addition no data concerning the malate consumption was shown.
In conclusion, the results of the present work revealed that the anti-
MLF peptidic fraction of 5–10 kDa produced by S. cerevisiae BDX was
gradually released during AF with an increasing inhibitory effectmainly
detected between the beginning and the late stages of the stationary
phase. The MLF inhibition due to the peptidic fraction was maintained
in natural winemaking conditions. It was shown for the ﬁrst time that
yeast proteinaceous compounds were able to inhibit the L-malic acid
consumption by directly targeting the malolactic enzyme activity. Cur-
rentwork is carried out in order to purify and sequence the putative bio-
active peptides of the 5–10 kDa fraction. Futurework should investigate
their antimicrobial range of action, their biochemical and inhibitory
properties and the possibility of using them as natural alternative
biopreservatives in food products.
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